Study Stopped
Design change
Clinical Investigation to Assess the Clinical Performance of the LumbaCure® Intervention on Chronic Low Back Pain Patients.
Randomized Clinical Investigation to Assess Preliminary Clinical Performance, Effectiveness and Safety of the LumbaCure® (prototype C190070.01) Medical Device When Used in Patients Suffering from Chronic Low Back Pain
1 other identifier
interventional
22
1 country
2
Brief Summary
Low Back Pain (LBP) is one of the common causes of morbidity worldwide, with a one-month prevalence of 23.3 %. Number of people with LBP reached 577 million people in 2020. LBP has been the leading cause of years lived with disability from 1990 to 2017. The highest incidence of LBP is in people in their third decade of age. LBP is a complex disease difficult to treat as most of these cases (80 - 90 %) are classified as non-specific meaning that the pain cannot be attributed to any specific injury or pathology. Until now exercise therapy is commonly used as the treatment of choice in the revalidation program of LBP. The aim of physical treatment is to improve function and prevent disability from getting worse. LumbaCure® is a robotic system driven by a proprietary movement algorithm to induce a specific and controlled mobilization of the hips and the low back in patient requiring treatment by physical exercises due to orthopedic disorder, especially low back pain. The investigation include an intervention period of 4 weeks The main objective is to compare the impact on disability (Oswestry disability Index) and movement performance of the interventions (LumbaCure® vs physical exercises supervised by the physiotherapist) in two parallel groups of patients suffering from chronic low back pain. The investigation includes an intervention period of 4 weeks and a follow-up period of 6 months (post intervention period).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2023
CompletedFirst Submitted
Initial submission to the registry
November 8, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 12, 2024
CompletedOctober 18, 2024
November 1, 2023
5 months
November 8, 2023
October 16, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Disability
The change of the Oswestry Disability Index (ODI) between baseline and the end of the intervention period (4 weeks)
Baseline, week 4 (end of intervention period)
Secondary Outcomes (16)
Disability
week2 (intervention period); month 1, month 3 and month 6 follow-up period
Disability responding rate
week 2, week 4 (intervention period) and at month 1, month 3 and month 6 follow-up period
Back Pain
week 1, week 2, week 3 and week 4 (the intervention period)
Back Pain
month 1, month 3 and month 6 (follow-up period)
Back Pain responding rate
week 2, week 4 (intervention period) and at month 1, month 3 and month 6 (follow-up period)
- +11 more secondary outcomes
Other Outcomes (7)
Patient mobilization
LumbaCure® session 1 and session 12 : Week 1 (Day 0) and Week 4 (Day 25)
Measurement in Dynamic/static situation
Baseline and week 4 (end of intervention period)
Measurement in Dynamic/static situation
Baseline and week 4 (end of intervention period)
- +4 more other outcomes
Study Arms (2)
Test Intervention arm
EXPERIMENTALThe LumbaCure® is a robotic system which provide active, specific and controlled mobilization of the low back. The device is to be used by the Physiotherapist at the rehabilitation centre. The duration of a session for the patient is 15 minutes. Patients follow a serie of 12 consecutive LumbaCure® sessions at a frequency of 3 sessions / week for 4 weeks.
Control Intervention arm
ACTIVE COMPARATORA set of core stability exercises/active qualitative mobilization has been defined with principal investigator according to the standard of care at Investigator site. At each session, 5 exercises will be selected by the investigator depending on the evolution and pathology of the patient. Five minutes of warm-up will be performed before starting the exercises session. The program will last 15 to 30 min depending on the time required for the patient to complete the prescribed exercises. Patients follow a serie of 12 consecutive physical exercises sessions at a frequency of 3 sessions / week for 4 weeks.
Interventions
LumbaCure®is a robotic system that systematically moves the spine of affected patients with a complex proprietary algorithm.
A set of core stability/active qualitative mobilization exercises have been defined, corresponding to standard exercises proposed in center rehabilitation program
Eligibility Criteria
You may qualify if:
- Chronic non-specific LBP (without red flag)
- Patient did not increase, on a long-term basis, his/her regular physical activity in the past 2 months.
- LBP is the principal musculoskeletal condition
- Aged between 18 and 65 years old
- Able to read and understand questionnaires and communicate with the physiotherapist.
- Average Back Pain intensity over the last week above 2, assessed on Numerical Pain Rating Scale from 0 to 10 anchored with "no pain" at 0 and "worst pain imaginable " at 10.
- ODI score \> 20
You may not qualify if:
- Suspected or confirmed serious pathology (i.e infection, fracture, cancer, inflammatory arthritis, ….)
- Radicular pain
- Radiculopathy
- Cognitive impairment that precludes participant from consenting, completing investigation questionnaires or complying with recommendations
- Previous spine surgery in the last 3 months
- Pregnant women
- body weight \> 120 kg
- Neurological disease
- Fibromyalgia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Odixlead
Study Sites (2)
Jessa Ziekenhuis vzw
Hasselt, 3500, Belgium
Jessa Ziekenhuis vzw
Herk-de-Stad, 3540, Belgium
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 8, 2023
First Posted
November 18, 2023
Study Start
October 2, 2023
Primary Completion
March 8, 2024
Study Completion
September 12, 2024
Last Updated
October 18, 2024
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share